Cercare Medical is pleased to join Sädeturvapäivät (Radiation Safety Days) 2026, Finland’s leading national event for professionals working with medical radiation. Organized by the Finnish Society of Radiology (SRY) and the Finnish Radiation Safety Authority (STUK), in cooperation with the Association of Hospital Physiologists and the Finnish Association of Radiologists, the event will take place on 29–30 October at Tampere Hall in Tampere, Finland.
Sädeturvapäivät provides an important forum for continuing education, discussion of current topics, and the exchange of knowledge and best practices in medical imaging and the use of radiation.
At Cercare Medical, we share this commitment to continued learning and the advancement of medical imaging. Our goal is to remain at the forefront of neuroimaging by providing advanced perfusion imaging solutions that transform imaging data into quantitative insights into brain tissue physiology.
See how Cercare Medical combines standard perfusion imaging with advanced biomarkers to provide a more detailed view of tissue physiology:
Cone-Beam CT (CBCT) Perfusion brings CT-quality perfusion imaging - along with Cercare Medical’s unique oxygen-metabolism biomarkers into the angio suite using the standard C-arm systems already in place. For the first time, interventional teams can assess tissue health and viability in real time, at the point of treatment.
Discover how Cone-Beam CT Perfusion can be integrated with syngo DynaCT Multiphase on the Siemens Healthineers ARTIS icono family. The solution extends the capabilities of Cercare Medical Neurosuite into the angio suite, providing advanced perfusion imaging to support clinicians during image-guided stroke treatment.
Visit us for live demonstrations of our latest perfusion and AI imaging solutions. Our team will be available throughout the event to discuss your clinical or research needs.
Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated and multi-vendor compatible software for CT, CBCT, and MRI perfusion imaging post-processing, we are committed to delivering cutting-edge technology that enhances patient care and advances medical diagnostics across various neurological conditions, including Stroke, Oncology, Alzheimer's, Dementia, and COVID-19. Our proprietary biomarkers allow for better, more precise imaging maps, improving decision-making in critical care and enhancing neuroimaging. This innovative technology has led to widespread adoption by leading hospitals and clinics around the world.
